Yuki Gosei Kogyo Co., Ltd. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2017
October 31, 2016 at 09:00 am EDT
Share
Yuki Gosei Kogyo Co., Ltd. announced non-consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported net sales of JPY 4,866 million compared to JPY 5,408 million a year ago. Operating income was JPY 146 million compared to JPY 266 million a year ago. Ordinary income was JPY 132 million compared to JPY 276 million a year ago. Net income was JPY 116 million compared to JPY 164 million a year ago. Net income per share was JPY 5.36 compared to JPY 7.54 a year ago.
For the fiscal year ending March 31, 2017, on non-consolidated basis, the company expects net sales of JPY 10,700 million, operating income of JPY 500 million, ordinary income of JPY 480 million, net income of JPY 310 million or net income per share of JPY 14.20.
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
Yuki Gosei Kogyo Co., Ltd. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2017